Moderna zeigt Interesse an BioNTech-Fertigungsstätten. Der Mainzer Konzern fährt das Corona-Geschäft zurück und fokussiert ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid ...
Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a patent dispute related to Pfizer (PFE) ...
Arbutus und Genevant reichen drei neue Klagen gegen BioNTech und Pfizer ein. Der Patentstreit um die Impfstofftechnologie ...
Arbutus Biopharma and its licensee Genevant filed three patent infringement lawsuits against Pfizer and BioNTech for its lipid nanoparticle technology. The clinical-stage biopharmaceutical company is ...
Stocktwits on MSN
ABUS stock on track for best day in about two months — what’s the Moderna connection?
On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.
Die wirtschaftlichen Flaggschiffe bereiten Sorgen: Eli Lilly, Boehringer Ingelheim, Biontech drohen mit Einschnitten - ...
Die wirtschaftlichen Flaggschiffe bereiten Sorgen: Eli Lilly, Boehringer Ingelheim und Biontech drohen mit Einschnitten - ...
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results